Hainan Shuangcheng Pharmaceuticals Hits Day High with 10.05% Surge

Hainan Shuangcheng Pharmaceuticals Co., Ltd. has experienced a significant surge in its stock price, gaining 10.05% on May 25, 2026. The stock reached an intraday high of CNY 11.61, reflecting strong market activity. This performance stands in contrast to the China Shanghai Composite, which only increased by 0.96% on the same day. Over the past month, Hainan Shuangcheng has shown impressive growth, with a 35.79% increase compared to the composite's 1.78%. Year-to-date, the stock has soared by 66.81%, significantly outperforming the composite's 4.63% gain. The company has also demonstrated robust financial health, reporting net sales of CNY 156.3 million, a remarkable growth of 92.49%. Additionally, its operating cash flow reached a record high of CNY 86.49 million, and net profit for the half-year stood at CNY 25.32 million. Despite a return on equity of 5.26% and a price-to-book ratio of 10.82, Hainan Shuangcheng's long-term performance remains strong, with a 173.18% increase over the past five years, showcasing its resilience in the pharmaceuticals and biotechnology sector.